Recombinant Human GCC1 Protein ，His & SUMO

GCC1, or GCC (Glycosylated Cell Surface Protein 1), is a type of protein that has gained attention in molecular and cell biology due to its potential roles in cell signaling and membrane dynamics. Initially identified in various organisms, GCC1 has been implicated in processes such as cell adhesion, growth, and differentiation. Research into GCC1 has shown its involvement in important biological pathways and its association with specific diseases, including cancer and autoimmune disorders. The need for recombinant GCC1 proteins arises from the limitations of native protein extraction, which often yields low quantities and purity. By employing recombinant DNA technology, researchers can produce large amounts of purified GCC1 protein, enabling detailed functional assays and structural studies. Such studies are critical for understanding the precise mechanisms of GCC1 in cellular contexts and elucidating its potential as a therapeutic target. Additionally, the exploration of GCC1 interactions with other cellular proteins enriches our knowledge of cellular networks, further emphasizing the importance of this protein in physiological and pathological conditions. Overall, GCC1 recombinant protein research stands at the intersection of basic biology and applied sciences, holding promise for advancements in drug development and disease treatment strategies.